Showing results (151-160 of 234) with videos related to

Sort By:
Pageof 24
Lung Cancer (Amsterdam, Netherlands)|August 29, 2015
Adherence to AIOM (Italian Association of Medical Oncology) lung cancer guidelines in Italian clinical practice: Results from the RIGHT-3 (research for the identification of the most effective and highly accepted clinical guidelines for cancer treatment) studySandro Barni, Evaristo Maiello, Massimo Di Maio, et al.
Oncology|July 16, 2005
Weekly docetaxel in pretreated metastatic breast cancer patients: a phase I-II studyCecilia Nisticò, Francesco Cognetti, Luciano Frontini, et al.
Future Oncology (London, England)|January 17, 2015
Does patient education work in breast cancer? Final results from the global CARIATIDE studyChristos Markopoulos, Patrick Neven, Minna Tanner, et al.
Breast (Edinburgh, Scotland)|March 29, 2014
The impact of educational materials on compliance and persistence rates with adjuvant aromatase inhibitor treatment: first-year results from the compliance of aromatase inhibitors assessment in daily practice through educational approach (CARIATIDE) studyPatrick Neven, Christos Markopoulos, Minna Tanner, et al.
Surgical Oncology|June 15, 2019
Risk of second primary tumors in GIST survivors: A systematic review and meta-analysisFausto Petrelli, Gianluca Tomasello, Sandro Barni, et al.
International Journal of Environmental Research and Public Health|September 10, 2021
An Analysis of the Social and Economic Costs of Breast Cancer in ItalyFrancesco Saverio Mennini, Marco Trabucco Aurilio, Simone Gazzillo, et al.
Anti-Cancer Drugs|March 8, 2006
Weekly paclitaxel, 5-fluorouracil and folinic acid with granulocyte colony-stimulating factor support in metastatic breast cancer patients: a phase II studyCecilia Nistico, Emilio Bria, Biagio Agostara, et al.
Recenti Progressi in Medicina|May 6, 2024
[What patients with cancer think about the dehospitalization. A survey of Cipomo.]Sandro Barni, Carlo Aschele, Livio Blasi, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 2015
Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer. An Italian Trials of Medical Oncology phase II studyMaria Di Bartolomeo, Andrea Ciarlo, Alessandro Bertolini, et al.
ESMO Open|December 18, 2018
Chemotherapy versus erlotinib as second-line treatment in patients with advanced non-small cell lung cancer and wild-type epidermal growth factor receptor: an individual patient data (IPD) analysisMarina Chiara Garassino, Tomoya Kawaguchi, Vanesa Gregorc, et al.
Pageof 24